section name header
References
Ulcerative Colitis - Related Resources
Cochrane reviews
There is insufficient evidence to make conclusions about the
efficacy
of
probiotics
compared to mesalazine
or
placebo
for maintenance of
remission
in ulcerative colitis
Probiotics Versus Mesalazine or Placebo for Maintenance of Remission in Ulcerative Colitis
.
There is insufficient evidence to make conclusions about the efficacy of probiotics compared to mesalazine or placebo for maintenance of remission in ulcerative colitis
Probiotics Versus Mesalazine or Placebo for Maintenance of Remission in Ulcerative Colitis
.
Oral
budesonide
might possibly offer no benefits compared to
mesalamine
or prednisolone in inducing remission in ulcerative colitis
Oral Budesonide for Induction of Remission in Ulcerative Colitis
.
Transdermal
nicotine
appears to be superior to placebo for the induction of remission in patient's with ulcerative colitis but there is no evidence of any significant advantage compared to standard
medical therapy
Transdermal Nicotine for Induction of Remission in Ulcerative Colitis
.
Non-enteric coated
omega 3
fatty acids
(
fish oil
) are probably not effective for maintenance of remission in ulcerative colitis
Omega 3 Fatty Acids for Maintenance of Remission in Ulcerative Colitis
.
Fish oil
as
an adjunct treatment may be beneficial for induction of remission in ulcerative colitis
Fish Oil for Induction of Remission in Ulcerative Colitis
.
There is insufficient evidence on the effect of probiotics
combined
with conventional treatment on induction of remission in ulcerative colitis
Probiotics for Induction of Remission in Ulcerative Colitis
.
Low dose
methotrexate
may not be effective in
remission induction
in active ulcerative colitis
Methotrexate for Induction of Remission in Ulcerative Colitis
.
Low dose oral methotrexate may not be effective for maintenance of remission in ulcerative colitis
Methotrexate for Maintenance of Remission in Ulcerative Colitis
.
Tacrolimus
may be effective for short-term improvement in
symptoms
in
patients
with treatment resistant ulcerative colitis
at
the cost of potential serious
side effects
. Insufficient treatment and
follow-up
intervals prevent any conclusions with regard to long-term
safety
and efficacy
Tacrolimus (Fk506) for Induction of Remission in Refractory Ulcerative Colitis
.
MLN-02 may be effective for induction of
clinical response
and remission in patients with moderately severe ulcerative colitis. Firm conclusions on safety cannot be drawn at this
time
Vedolizumab for Induction and Maintenance of Remission in Ulcerative Colitis
.
There may not be differences in
mortality
or complication rates between open and laparoscopic approach to pouch
surgery
in patients with ulcerative colitis and
familial adenomatous polyposis
, but the laparoscopic approach may result in better
cosmesis
Open Versus Laparoscopic (Assisted) Ileo Pouch Anal Anastomosis for Ulcerative Colitis and Familial Adenomatous Polyposis
.
There is insufficient evidence on the impact of
specialist
nursing
interventions on the care and
management
of patients with
inflammatory bowel
disease
Specialist Nursing Interventions for Inflammatory Bowel Disease
.
Other evidence summaries
Inflammatory bowel disease patients
who
receive immunomodulator medications may be at higher
risk
of lymphoma than the general population. This increased risk could be due to the
medication
, disease activity, or both
Lymphoma Risk Among Inflammatory Bowel Disease Patients Treated with Azathioprine or 6-Mercaptopurine
.
Other
Internet
resources
Ulcerative colitis. Orphanet ORPHA771
http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=34
Primary/Secondary Keywords
Related resources